Brief: Kala Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Financial Results

KALA BIO

03/03/2023 13:05

March 3 (Reuters) - Kala Pharmaceuticals Inc  KALA.O :
    * KALA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * CLOSED $31.0 MILLION PRIVATE PLACEMENT FINANCING,
EXTENDING CASH
RUNWAY INTO 1Q 2025
    * DID NOT RECOGNIZE PRODUCT REVENUES IN Q4 OF 2022,
FOLLOWING SALE
OF ITS COMMERCIAL PORTFOLIO TO ALCON ON JULY 8, 2022
    * QTRLY BASIC AND DILUTED LOSS PER SHARE $7.97

Source text for Eikon:  ID:nGNX94v0ym 
Further company coverage:  KALA.O